NMC
VTAE

NEA Management Company’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

NEA Management Company’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,613,199
Closed -$37.6M – 36
2015
Q2 		$37.6M Hold
2,613,199
– – 1.97% 11
2015
Q1 		$30.6M Hold
2,613,199
– – 1.38% 15
2014
Q4 		$43.5M Hold
2,613,199
– – 2.11% 15
2014
Q3 		$19.9M Buy
+2,613,199
New +$20.3M 1.01% 21

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

NEA Management Company's VTAE Position: Q3 2015 in Review

NEA Management Company sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2015, closing a stake of 2,613,199 shares — an estimated $37.6M sold.

NEA Management Company first reported a position in VTAE in Q3 2014 and held it in 4 quarters. The position peaked at $43.5M in Q4 2014. 70 funds tracked by Wall St. Rank hold VTAE as of Q3 2015.

  • NEA Management Company reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2015 after selling out during the quarter.
  • NEA Management Company sold 2,613,199 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2015, an estimated $37.6M.
  • NEA Management Company first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2014 and held it in 4 quarters.
  • NEA Management Company's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $43.5M in Q4 2014.
  • 70 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2015.

Based on NEA Management Company's 13F filing for Q3 2015, filed 10 Nov 2015.